# EDGAR Filing Document

**Accession Number:** 0000845982
**File Stem:** 0001654954-26-003209
**Filing Date:** 2026-4
**Character Count:** 13014
**Document Hash:** c9bb012f2d233ae564b60c65004dd417
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-003209.hdr.sgml**: 20260402

**ACCESSION NUMBER**: 0001654954-26-003209

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260402

**FILED AS OF DATE**: 20260402

**DATE AS OF CHANGE**: 20260402

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SMITH & NEPHEW PLC
- **CENTRAL INDEX KEY:** 0000845982
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14978
- **FILM NUMBER:** 26831041

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING 5, CROXLEY PARK
- **STREET 2:** HATTERS LANE
- **CITY:** WATFORD, HERTFORDSHIRE
- **PROVINCE COUNTRY:** X0
- **ZIP:** WD18 8YE
- **BUSINESS PHONE:** 44 (0) 1923 477 100

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING 5, CROXLEY PARK
- **STREET 2:** HATTERS LANE
- **CITY:** WATFORD, HERTFORDSHIRE
- **PROVINCE COUNTRY:** X0
- **ZIP:** WD18 8YE

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **Form 6-K**

 **Report of Foreign Private Issuer**

 **Pursuant to Rule 13a-16 or 15d-16 under the**

 **Securities Exchange Act of 1934**

April 02, 2026

Commission File Number 001-14978

 **SMITH & NEPHEW plc**

(Registrant's name)

 **Building 5, Croxley Park, Hatters Lane**

 **Watford, England, WD18 8YE**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F <u>✔</u> Form 40-F __

 **SMITH & NEPHEW PLC**

 **2 April 2026**

 **NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM**

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 **1. AWARDS MADE UNDER THE SMITH & NEPHEW PLC DEFERRED SHARE BONUS PLAN**

On 1 April 2026, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Deferred Share Bonus Plan. The number of Shares awarded has been calculated using a market price of £12.744 per Share, being the average of the quoted closing prices of a Share for the ten (10) dealing days immediately following the announcement of the Company's full year 2025 results on 2 March 2026.

A portion (50%) of the annual bonus earned by the following Executive Directors for performance during the year to 31 December 2025 has been deferred into share awards. The awards will normally vest on 15 March 2029. The Executive Directors will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant vesting period.

---

| | |
|:---|:---|
| **Reason for the notification** | **Reason for the notification** |
| Initial notification /Amendment | Initial notification |
| **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** |
| Description of the financial instrument, type of instrument<br>| Ordinary Shares of USD 0.20 each<br>|
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Awards granted on 1 April 2026 under the Deferred Share Bonus Plan. |
| Date of Transaction | 2026 - 04 - 01 |
| Place of Transaction | Grant took place outside a trading venue |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**<br> **(Position)** | **Status** | **Price (s)** | **Volume(s)** | **Aggregated information** |
| Deepak Nath<br> (Chief Executive Officer) | Director | £12.744 | 83494 | N/A Single Transaction |
| John Rogers<br> (Chief Financial Officer) | Director | £12.744 | 48071 | N/A Single Transaction |

---

 **2. PERFORMANCE SHARE AWARDS MADE UNDER THE SMITH & NEPHEW PLC GLOBAL SHARE PLAN 2020**

On 1 April 2026, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Global Share Plan 2020. The number of Shares awarded has been calculated using a market price of £12.744 per Share, being the average of the quoted closing prices of a Share for the ten (10) dealing days immediately following the announcement of the Company's full year 2025 results on 2 March 2026.

Awards will vest on 15 March 2029, subject to the achievement of performance conditions which are measured over the period 1 January 2026 to 31 December 2028.

The number of shares subject to the above awards are shown at maximum vesting. Should less than maximum vesting be achieved, participants will receive a reduced number of shares in accordance with actual performance. Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

---

| | |
|:---|:---|
| **Reason for the notification** | **Reason for the notification** |
| Initial notification /Amendment | Initial notification |
| **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** |
| Description of the financial instrument, type of instrument<br>| Ordinary Shares of USD 0.20 each<br>|
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Awards granted on 1 April 2026 under the Global Share Plan 2020. |
| Date of Transaction | 2026 - 04 - 01 |
| Place of Transaction | Grant took place outside a trading venue |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**<br> **(Position)** | **Status** | **Price (£)** | **Volume** | **Aggregated information** |
| Deepak Nath<br> (Chief Executive Officer) | PDMR | £12.744 | 285473 | N/A Single Transaction |
| John Rogers<br> (Chief Financial Officer) | PDMR | £12.744 | 154229 | N/A Single Transaction |
| Helen Barraclough<br> (Group General Counsel & Company Secretary) | PDMR | £12.744 | 55550 | N/A Single Transaction |
| Paul Connolly<br> (President, Global Operations) | PDMR | £12.744 | 51531 | N/A Single Transaction |
| Ajay Dhankhar<br> (Chief Strategy & Corporate Development Officer) | PDMR | £12.744 | 110751 | N/A Single Transaction |
| Craig Gaffin<br> (President Orthopaedics) | PDMR | £12.744 | 91258 | N/A Single Transaction |
| Rohit Kashyap<br> (President AWM & Global Commercial Operations) | PDMR | £12.744 | 112073 | N/A Single Transaction |
| Mizanu Kebede<br> (Chief Quality & Regulatory Affairs Officer) | PDMR | £12.744 | 53921 | N/A Single Transaction |
| Elga Lohler<br> (Chief HR Officer) | PDMR | £12.744 | 67747 | N/A Single Transaction |
| Vasant Padmanabhan<br> (President Research & Development, ENT & Emerging Markets) | PDMR | £12.744 | 71044 | N/A Single Transaction |
| Alison Parkes<br> (Chief Compliance Officer) | PDMR | £12.744 | 19679 | N/A Single Transaction |
| Scott Schaffner<br> (Global President Sports Medicine) | PDMR | £12.744 | 107053 | N/A Single Transaction |

---

 **3. AWARDS MADE UNDER THE SMITH & NEPHEW PLC RESTRICTED SHARE PLAN 2024**

On 1 April 2026, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Restricted Share Plan 2024. The number of Shares awarded has been calculated using a market price of £12.744 per Share, being the average of the quoted closing prices of a Share for the ten (10) dealing days immediately following the announcement of the Company's full year 2025 results on 2 March 2026.

The awards will normally vest in equal annual tranches over three years following the award date. In addition, Deepak Nath's and John Rogers' awards are subject to a reasonable judgement underpin. If the Remuneration Committee is not satisfied that the underpin has been met, the Committee may scale back the vesting (including to zero). In assessing the underpin, the Committee will consider a review of overall financial performance over the vesting period, whether there have been any sanctions or fines issued by a regulatory authority, whether there have been any material environmental, social or governance issues, whether a major safety incident has occurred and whether there has been material damage to the reputation of the Company.

Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant vesting period.

---

| | |
|:---|:---|
| **Reason for the notification** | **Reason for the notification** |
| Initial notification /Amendment | Initial notification |
| **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted** |
| Description of the financial instrument, type of instrument<br>| Ordinary Shares of USD 0.20 each<br>|
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Awards granted on 1 April 2026 under the Restricted Share Plan 2024. |
| Date of Transaction | 2026 - 04 - 01 |
| Place of Transaction | Grant took place outside a trading venue |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**<br> **(Position)** | **Status** | **Price (£)** | **Volume** | **Aggregated information** |
| Deepak Nath<br> (Chief Executive Officer) | PDMR | £12.744 | 118947 | N/A Single Transaction |
| John Rogers<br> (Chief Financial Officer) | PDMR | £12.744 | 64262 | N/A Single Transaction |
| Helen Barraclough<br> (Group General Counsel & Company Secretary) | PDMR | £12.744 | 21927 | N/A Single Transaction |
| Paul Connolly<br> (President, Global Operations) | PDMR | £12.744 | 26443 | N/A Single Transaction |
| Ajay Dhankhar<br> (Chief Strategy & Corporate Development Officer) | PDMR | £12.744 | 42009 | N/A Single Transaction |
| Craig Gaffin<br> (President Orthopaedics) | PDMR | £12.744 | 24230 | N/A Single Transaction |
| Rohit Kashyap<br> (President AWM & Global Commercial Operations) | PDMR | £12.744 | 55263 | N/A Single Transaction |
| Mizanu Kebede<br> (Chief Quality & Regulatory Affairs Officer) | PDMR | £12.744 | 21284 | N/A Single Transaction |
| Elga Lohler<br> (Chief HR Officer) | PDMR | £12.744 | 34764 | N/A Single Transaction |
| Vasant Padmanabhan<br> (President Research & Development, ENT & Emerging Markets) | PDMR | £12.744 | 28043 | N/A Single Transaction |
| Alison Parkes<br> (Chief Compliance Officer) | PDMR | £12.744 | 7379 | N/A Single Transaction |
| Scott Schaffner<br> (President Sports Medicine) | PDMR | £12.744 | 64970 | N/A Single Transaction |

---

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **Smith & Nephew plc** |
|  |  | (Registrant) |
| Date: April 02, 2026 | By: | /s/ Helen Barraclough |
|  |  | Helen Barraclough |
|  |  | Company Secretary |

---